[SINOPEG] (heptadecan-9-yl 8-((2-hydroxyethyl)(6-oxO-6-(undecyloxy) hexyl) amino) octanoate) | 2089251-47-6

[SINOPEG 한국공식대리점]

[SINOPEG] (heptadecan-9-yl 8-((2-hydroxyethyl)(6-oxO-6-(undecyloxy) hexyl) amino) octanoate) | 2089251-47-6

Product Information:

• Alternate Name: Heptadecan-9-yl 8-((2-hydroxyethyl) (6-oxo-6-(undecyloxy) hexyl) amino) octanoate)
• Abbreviation: SM-102, HUO
• CAS: 2089251-47-6
• Package Size: 1g/bottle, 10g/bottle, 100g/bottle
• Storage: Store at -20±5℃, keep dry
• research use only

Reference:

• Wan J, Wang C, Wang Z, et al. CXCL13 promotes broad immune responses induced by circular RNA vaccines. Proc Natl Acad Sci U S A. 2024;121(44):e2406434121. doi:10.1073/pnas.2406434121
• Wang L, Wan J, He W, et al. IL-7 promotes mRNA vaccine-induced long-term immunity. J Nanobiotechnology. 2024;22(1):716. Published 2024 Nov 16. doi:10.1186/s12951-024-02993-5
• Tong H, Ma Z, Yu J, et al. Optimizing Peptide-Conjugated Lipid Nanoparticles for Efficient siRNA Delivery across the Blood-Brain Barrier and Treatment of Glioblastoma Multiforme. ACS Chem Biol. 2025;20(4):942-952. doi:10.1021/acschembio.5c00039
• Shao X, Liu L, Weng C, et al. Leveraging an mRNA Platform for the Development of Vaccines Against Egg Allergy. Vaccines (l). 2025;13(5):448. Published 2025 Apr 24. doi:10.3390/vaccines13050448
• Deng X, Yang Y, Gan L, et al. Engineering Lipid Nanoparticles to Enhance Intracellular Delivery of Transforming Growth Factor-Beta siRNA (siTGF-β1) via Inhalation for Improving Pulmonary Fibrosis Post-Bleomycin Challenge. Pharmaceutics. 2025;17(2):157. Published 2025 Jan 24. doi:10.3390/pharmaceutics17020157

어스바이오(USBIO)는 SINOPEG 한국 공식 대리점입니다.
해당 제품에 대한 문의나 SINOPEG 제품의 견적 또는 문의사항이 있으시면 아래로 연락주시기 바랍니다.
Tel : 02-862-2816 / email : bio@usbio.co.kr